• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光遗传学激活异三聚体 G 蛋白通过 LOV2GIVe,一种合理设计的模块化蛋白。

Optogenetic activation of heterotrimeric G-proteins by LOV2GIVe, a rationally engineered modular protein.

机构信息

Department of Biochemistry, Boston University School of Medicine, Boston, United States.

出版信息

Elife. 2020 Sep 16;9:e60155. doi: 10.7554/eLife.60155.

DOI:10.7554/eLife.60155
PMID:32936073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7515630/
Abstract

Heterotrimeric G-proteins are signal transducers involved in mediating the action of many natural extracellular stimuli and many therapeutic agents. Non-invasive approaches to manipulate the activity of G-proteins with high precision are crucial to understand their regulation in space and time. Here, we developed LOV2GIVe, an engineered modular protein that allows the activation of heterotrimeric G-proteins with blue light. This optogenetic construct relies on a versatile design that differs from tools previously developed for similar purposes, that is metazoan opsins, which are light-activated G-protein-coupled receptors (GPCRs). Instead, LOV2GIVe consists of the fusion of a G-protein activating peptide derived from a non-GPCR regulator of G-proteins to a small plant protein domain, such that light uncages the G-protein activating module. Targeting LOV2GIVe to cell membranes allowed for light-dependent activation of Gi proteins in different experimental systems. In summary, LOV2GIVe expands the armamentarium and versatility of tools available to manipulate heterotrimeric G-protein activity.

摘要

异三聚体 G 蛋白是信号转导因子,参与介导许多天然细胞外刺激物和许多治疗药物的作用。非侵入性方法来精确地操纵 G 蛋白的活性对于理解它们在空间和时间上的调节至关重要。在这里,我们开发了 LOV2GIVe,这是一种经过工程改造的模块化蛋白,允许用蓝光激活异三聚体 G 蛋白。这种光遗传学构建体依赖于一种通用的设计,与以前为类似目的开发的工具(即后生动物视蛋白,即光激活的 G 蛋白偶联受体(GPCR))不同。相反,LOV2GIVe 由源自非 GPCR G 蛋白调节剂的 G 蛋白激活肽与一个小的植物蛋白结构域融合而成,从而使 G 蛋白激活模块光解笼。将 LOV2GIVe 靶向质膜,可在不同的实验系统中用光依赖性激活 Gi 蛋白。总之,LOV2GIVe 扩展了用于操纵异三聚体 G 蛋白活性的工具的武器装备和多功能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/f753952b4e4d/elife-60155-resp-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/bc65584be857/elife-60155-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/7c9cb03933fc/elife-60155-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/bef8df0162e8/elife-60155-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/27088c7a0b95/elife-60155-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/5ea93f5a64b8/elife-60155-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/d3181ce4e504/elife-60155-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/19cced191962/elife-60155-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/8775b943322a/elife-60155-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/334bf6dddbe5/elife-60155-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/f753952b4e4d/elife-60155-resp-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/bc65584be857/elife-60155-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/7c9cb03933fc/elife-60155-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/bef8df0162e8/elife-60155-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/27088c7a0b95/elife-60155-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/5ea93f5a64b8/elife-60155-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/d3181ce4e504/elife-60155-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/19cced191962/elife-60155-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/8775b943322a/elife-60155-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/334bf6dddbe5/elife-60155-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/7515630/f753952b4e4d/elife-60155-resp-fig1.jpg

相似文献

1
Optogenetic activation of heterotrimeric G-proteins by LOV2GIVe, a rationally engineered modular protein.光遗传学激活异三聚体 G 蛋白通过 LOV2GIVe,一种合理设计的模块化蛋白。
Elife. 2020 Sep 16;9:e60155. doi: 10.7554/eLife.60155.
2
Heterotrimeric G protein signaling without GPCRs: The Gα-binding-and-activating (GBA) motif.没有 G 蛋白偶联受体的异三聚体 G 蛋白信号转导:Gα 结合和激活(GBA)基序。
J Biol Chem. 2024 Mar;300(3):105756. doi: 10.1016/j.jbc.2024.105756. Epub 2024 Feb 15.
3
Specific inhibition of GPCR-independent G protein signaling by a rationally engineered protein.通过合理设计的蛋白质特异性抑制非 G 蛋白偶联受体的 G 蛋白信号转导。
Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):E10319-E10328. doi: 10.1073/pnas.1707992114. Epub 2017 Nov 13.
4
Membrane Recruitment of the Non-receptor Protein GIV/Girdin (Gα-interacting, Vesicle-associated Protein/Girdin) Is Sufficient for Activating Heterotrimeric G Protein Signaling.非受体蛋白GIV/Girdin(Gα相互作用、囊泡相关蛋白/Girdin)的膜募集足以激活异源三聚体G蛋白信号传导。
J Biol Chem. 2016 Dec 30;291(53):27098-27111. doi: 10.1074/jbc.M116.764431. Epub 2016 Nov 18.
5
Engineering a V(2) vasopressin receptor agonist- and regulator of G-protein-signaling-sensitive G protein.构建一种对血管加压素V2受体激动剂和G蛋白信号调节敏感的G蛋白。
Anal Biochem. 2002 Jan 15;300(2):212-20. doi: 10.1006/abio.2001.5448.
6
The GAPs, GEFs, GDIs and…now, GEMs: New kids on the heterotrimeric G protein signaling block.GAPs、GEFs、GDIs以及……现在还有GEMs:异源三聚体G蛋白信号传导领域的新成员。
Cell Cycle. 2017 Apr 3;16(7):607-612. doi: 10.1080/15384101.2017.1282584. Epub 2017 Mar 13.
7
G protein-coupled receptor Kinase 2/G alpha q/11 interaction. A novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits.G蛋白偶联受体激酶2/Gαq/11相互作用。G蛋白信号调节同源结构域上一个用于结合Gα亚基的新表面。
J Biol Chem. 2003 Feb 21;278(8):6050-8. doi: 10.1074/jbc.M208787200. Epub 2002 Nov 8.
8
Rapid kinetic BRET measurements to monitor G protein activation by GPCR and non-GPCR proteins.用于监测G蛋白偶联受体(GPCR)和非GPCR蛋白激活G蛋白的快速动力学生物发光共振能量转移(BRET)测量。
Methods Cell Biol. 2017;142:145-157. doi: 10.1016/bs.mcb.2017.08.001. Epub 2017 Sep 12.
9
Characterization of GRK2 RH domain-dependent regulation of GPCR coupling to heterotrimeric G proteins.GRK2的RH结构域依赖性调节GPCR与异源三聚体G蛋白偶联的特性分析。
Methods Enzymol. 2004;390:310-36. doi: 10.1016/S0076-6879(04)90020-1.
10
Plant heterotrimeric G protein beta subunit is associated with membranes via protein interactions involving coiled-coil formation.植物异源三聚体G蛋白β亚基通过涉及卷曲螺旋形成的蛋白质相互作用与膜相关联。
FEBS Lett. 2000 Jul 7;476(3):208-12. doi: 10.1016/s0014-5793(00)01706-3.

引用本文的文献

1
Principles and Design of Molecular Tools for Sensing and Perturbing Cell Surface Receptor Activity.用于感知和扰动细胞表面受体活性的分子工具的原理与设计
Chem Rev. 2025 Mar 12;125(5):2665-2702. doi: 10.1021/acs.chemrev.4c00582. Epub 2025 Feb 25.
2
AGS3-based optogenetic GDI induces GPCR-independent Gβγ signalling and macrophage migration.基于AGS3的光遗传学鸟苷酸解离抑制剂诱导不依赖G蛋白偶联受体的Gβγ信号传导和巨噬细胞迁移。
Open Biol. 2025 Feb;15(2):240181. doi: 10.1098/rsob.240181. Epub 2025 Feb 5.
3
AGS3-based optogenetic GDI induces GPCR-independent Gβγ signaling and macrophage migration.

本文引用的文献

1
Probing the mutational landscape of regulators of G protein signaling proteins in cancer.探究 G 蛋白信号转导调节蛋白在癌症中的突变特征。
Sci Signal. 2020 Feb 4;13(617):eaax8620. doi: 10.1126/scisignal.aax8620.
2
DAPLE protein inhibits nucleotide exchange on Gα and Gα via the same motif that activates Gαi.DAPLE 蛋白通过激活 Gαi 的相同基序抑制 Gα 和 Gα 的核苷酸交换。
J Biol Chem. 2020 Feb 21;295(8):2270-2284. doi: 10.1074/jbc.RA119.011648. Epub 2020 Jan 16.
3
Structural basis for GPCR-independent activation of heterotrimeric Gi proteins.
基于AGS3的光遗传学鸟苷酸解离抑制剂诱导不依赖G蛋白偶联受体的Gβγ信号传导和巨噬细胞迁移。
bioRxiv. 2024 Jun 5:2024.06.04.597473. doi: 10.1101/2024.06.04.597473.
4
Heterotrimeric G protein signaling without GPCRs: The Gα-binding-and-activating (GBA) motif.没有 G 蛋白偶联受体的异三聚体 G 蛋白信号转导:Gα 结合和激活(GBA)基序。
J Biol Chem. 2024 Mar;300(3):105756. doi: 10.1016/j.jbc.2024.105756. Epub 2024 Feb 15.
5
Dissecting the molecular basis for the modulation of neurotransmitter GPCR signaling by GINIP.解析 GINIP 调节神经递质 GPCR 信号转导的分子基础。
Structure. 2024 Jan 4;32(1):47-59.e7. doi: 10.1016/j.str.2023.10.010. Epub 2023 Nov 20.
6
Optical Approaches for Investigating Neuromodulation and G Protein-Coupled Receptor Signaling.光学方法研究神经调制和 G 蛋白偶联受体信号转导。
Pharmacol Rev. 2023 Nov;75(6):1119-1139. doi: 10.1124/pharmrev.122.000584. Epub 2023 Jul 10.
7
Fine-tuning GPCR-mediated neuromodulation by biasing signaling through different G protein subunits.通过不同 G 蛋白亚基对信号转导进行偏向性调节来精细调控 G 蛋白偶联受体介导的神经调制。
Mol Cell. 2023 Jul 20;83(14):2540-2558.e12. doi: 10.1016/j.molcel.2023.06.006. Epub 2023 Jun 29.
8
Dissecting the molecular basis for the modulation of neurotransmitter GPCR signaling by GINIP.剖析GINIP对神经递质G蛋白偶联受体(GPCR)信号传导进行调控的分子基础。
bioRxiv. 2023 Apr 21:2023.04.20.537566. doi: 10.1101/2023.04.20.537566.
9
Design and engineering of light-sensitive protein switches.光敏蛋白开关的设计与工程。
Curr Opin Struct Biol. 2022 Jun;74:102377. doi: 10.1016/j.sbi.2022.102377. Epub 2022 Apr 20.
10
Building unconventional G protein-coupled receptors, one block at a time.一次构建一个非传统的 G 蛋白偶联受体。
Trends Pharmacol Sci. 2021 Jul;42(7):514-517. doi: 10.1016/j.tips.2021.04.005. Epub 2021 May 10.
G 蛋白偶联受体非依赖性激活异三聚体 Gi 蛋白的结构基础。
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16394-16403. doi: 10.1073/pnas.1906658116. Epub 2019 Jul 30.
4
Coupling of Human Rhodopsin to a Yeast Signaling Pathway Enables Characterization of Mutations Associated with Retinal Disease.将人视蛋白与酵母信号通路偶联可用于鉴定与视网膜疾病相关的突变。
Genetics. 2019 Feb;211(2):597-615. doi: 10.1534/genetics.118.301733. Epub 2018 Dec 4.
5
A biochemical and genetic discovery pipeline identifies PLCδ4b as a nonreceptor activator of heterotrimeric G-proteins.生化和遗传发现管道将 PLCδ4b 鉴定为异三聚体 G 蛋白的非受体激活剂。
J Biol Chem. 2018 Nov 2;293(44):16964-16983. doi: 10.1074/jbc.RA118.003580. Epub 2018 Sep 7.
6
A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action.一种基因编码生物传感器揭示了阿片类药物作用的位置偏向。
Neuron. 2018 Jun 6;98(5):963-976.e5. doi: 10.1016/j.neuron.2018.04.021. Epub 2018 May 10.
7
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?G 蛋白偶联受体作为已批准药物的靶点:有多少个靶点和多少种药物?
Mol Pharmacol. 2018 Apr;93(4):251-258. doi: 10.1124/mol.117.111062. Epub 2018 Jan 3.
8
Specific inhibition of GPCR-independent G protein signaling by a rationally engineered protein.通过合理设计的蛋白质特异性抑制非 G 蛋白偶联受体的 G 蛋白信号转导。
Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):E10319-E10328. doi: 10.1073/pnas.1707992114. Epub 2017 Nov 13.
9
When Heterotrimeric G Proteins Are Not Activated by G Protein-Coupled Receptors: Structural Insights and Evolutionary Conservation.当异源三聚体G蛋白不被G蛋白偶联受体激活时:结构见解与进化保守性
Biochemistry. 2018 Jan 23;57(3):255-257. doi: 10.1021/acs.biochem.7b00845. Epub 2017 Oct 16.
10
The Gαi-GIV binding interface is a druggable protein-protein interaction.Gαi-GIV 结合界面是一个可成药的蛋白-蛋白相互作用。
Sci Rep. 2017 Aug 17;7(1):8575. doi: 10.1038/s41598-017-08829-7.